KWBT logo

Kiwa Bio-Tech Products Group Corporation (KWBT) Análisis de Acciones

Solo con fines informativos. No es asesoramiento financiero. Analysis by Sedat Aydin, Founder & Editor-in-Chief | AI-powered analysis. Data sourced from SEC filings and institutional-grade financial providers. Editorially reviewed. Not financial advice.

Kiwa Bio-Tech Products Group Corporation (KWBT) opera en el sector Basic Materials, cotizado por última vez a $ con una capitalización de mercado de 0. La acción obtiene una puntuación de 51/100, una calificación moderada basada en 9 KPI cuantitativos.

Ultimo analisis: 17 mar 2026
Puntuación de IA de 51/100

Kiwa Bio-Tech Products Group Corporation (KWBT) Exposición a Materiales y Productos Básicos

CEOZiqi Wang
Empleados16
Sede CentralYangling, CN
Año de la oferta pública inicial (OPI)2002

Kiwa Bio-Tech Products Group Corporation focuses on developing and distributing bio-fertilizers in the Chinese agricultural market, leveraging strategic partnerships and proprietary technology to offer sustainable solutions for crop yield enhancement and soil health, operating within a competitive landscape of both domestic and international players.

Procedencia de los datos | Datos financieros Análisis cuantitativo NASDAQ Análisis: 17 mar 2026

Tesis de Inversión

Kiwa Bio-Tech Products Group Corporation presents a focused play on the growing demand for bio-fertilizers in China. The company's strategic partnerships with research institutions and its range of bio-fertilizer products position it to capitalize on the increasing adoption of sustainable agricultural practices. However, the company's negative profit margin of -16.6% and lack of dividend payments raise concerns about its financial stability. The high beta of 2.91 suggests significant volatility. Future growth hinges on successful product commercialization, expansion of distribution networks, and effective management of operational costs. Investors should closely monitor the company's ability to achieve profitability and generate positive cash flow.

Basado en las finanzas de FMP y el análisis cuantitativo

Puntos clave

  • Kiwa Bio-Tech operates in the agricultural inputs sector, focusing on bio-fertilizers.
  • The company's products include bacillus species-based biological organic, compound microbial, bio-water soluble, and microbial inoculum fertilizers.
  • Kiwa Bio-Tech has strategic cooperation agreements with several agricultural research institutions in China.
  • The company's gross margin is 23.3%.
  • The company's profit margin is -16.6%.

Competidores y Pares

Fortalezas

  • Proprietary bio-fertilizer technology
  • Strategic partnerships with research institutions
  • Established presence in the Chinese market
  • Focus on sustainable agriculture

Debilidades

  • Negative profit margin
  • Limited financial resources
  • Dependence on the Chinese market
  • Small number of employees

Catalizadores

  • Ongoing: Increasing demand for bio-fertilizers in China due to environmental concerns and government support.
  • Ongoing: Strategic partnerships with research institutions to develop innovative products.
  • Upcoming: Potential expansion into new geographic markets within China.
  • Upcoming: Development and launch of new bio-fertilizer products targeting specific crops.
  • Ongoing: Government subsidies and incentives for sustainable agriculture practices.

Riesgos

  • Ongoing: Competition from larger agricultural companies with greater resources.
  • Potential: Fluctuations in raw material prices affecting production costs.
  • Potential: Changes in government regulations impacting the bio-fertilizer industry.
  • Potential: Economic slowdown in China reducing demand for agricultural products.
  • Ongoing: Limited financial resources and negative profit margin.

Oportunidades de crecimiento

  • Expansion of Product Line: Kiwa Bio-Tech can expand its product line to include a wider range of bio-fertilizers and related agricultural products. This could involve developing new formulations, targeting specific crops, or addressing specific soil conditions. The market for specialized bio-fertilizers is growing, as farmers seek tailored solutions for their needs. This expansion could increase revenue streams and market share, with a potential market size of $5 billion by 2030.
  • Geographic Expansion within China: Kiwa Bio-Tech can expand its geographic reach within China, targeting regions with high agricultural activity and a growing demand for bio-fertilizers. This could involve establishing new distribution partnerships, opening regional offices, or participating in agricultural trade shows. The Chinese agricultural market is vast and diverse, offering significant opportunities for growth. This expansion could increase sales volume and brand awareness, with a timeline of 3-5 years.
  • Strategic Partnerships and Acquisitions: Kiwa Bio-Tech can pursue strategic partnerships and acquisitions to enhance its technological capabilities, expand its product portfolio, or gain access to new markets. This could involve collaborating with research institutions, acquiring smaller bio-fertilizer companies, or partnering with agricultural distributors. Strategic alliances can accelerate growth and create synergies, with ongoing opportunities.
  • Increased Focus on Research and Development: Kiwa Bio-Tech can increase its investment in research and development to develop innovative bio-fertilizer products and improve existing formulations. This could involve conducting field trials, collaborating with universities, or hiring experienced scientists. Innovation is crucial for maintaining a competitive edge in the bio-fertilizer market, with a continuous timeline.
  • Government Support and Subsidies: Kiwa Bio-Tech can leverage government support and subsidies for the development and adoption of bio-fertilizers. The Chinese government is actively promoting sustainable agriculture and providing financial incentives for farmers to use environmentally friendly products. This support can reduce costs and increase demand for Kiwa Bio-Tech's products, with ongoing opportunities.

Oportunidades

  • Expanding product line
  • Geographic expansion within China
  • Increasing demand for bio-fertilizers
  • Government support for sustainable agriculture

Amenazas

  • Competition from larger agricultural companies
  • Fluctuations in raw material prices
  • Changes in government regulations
  • Economic slowdown in China

Ventajas competitivas

  • Proprietary bio-fertilizer formulations
  • Strategic partnerships with research institutions
  • Established distribution network in China
  • Brand recognition in the Chinese agricultural market

Acerca de KWBT

Kiwa Bio-Tech Products Group Corporation, established in 2002 and headquartered in Yangling, China, is dedicated to the development, manufacturing, and distribution of bio-technological products tailored for the agricultural sector. The company's core offerings include a range of bio-fertilizers, encompassing bacillus species-based biological organic fertilizers, compound microbial fertilizers, bio-water soluble fertilizers, and microbial inoculum fertilizers. These products are designed to enhance crop yields, improve soil health, and promote sustainable agricultural practices. Kiwa Bio-Tech has strategically aligned itself with key institutions such as the Beijing Zhongpin Agricultural Science and Technology Development Center, the China Academy of Agricultural Science's Institute of Agricultural Resources & Regional Planning, and the Institute of Agricultural Economy & Development, as well as Kiwa Bio-Tech (Yangling) Co. Ltd. These collaborations facilitate research, development, and market access within the Chinese agricultural landscape. The company's focus on bio-fertilizers addresses the growing demand for environmentally friendly agricultural solutions in China, driven by increasing awareness of soil degradation and the need for sustainable farming practices.

Qué hacen

  • Develops bio-technological products for the agricultural market.
  • Manufactures bio-fertilizers.
  • Markets bio-fertilizers.
  • Distributes bio-fertilizers.
  • Offers bacillus species-based biological organic fertilizers.
  • Offers compound microbial fertilizers.
  • Offers bio-water soluble fertilizers.
  • Offers microbial inoculum fertilizers.

Modelo de Negocio

  • Develops and manufactures bio-fertilizers.
  • Sells bio-fertilizers to distributors and farmers.
  • Generates revenue through product sales.
  • Forms strategic partnerships for research and development.

Contexto de la Industria

Kiwa Bio-Tech operates within the agricultural inputs industry, specifically focusing on the bio-fertilizer segment. The Chinese agricultural sector is undergoing a shift towards sustainable practices, driven by government regulations and increasing awareness of environmental concerns. The market for bio-fertilizers is growing, as farmers seek alternatives to traditional chemical fertilizers. Kiwa Bio-Tech competes with both domestic and international players in this space. The industry is characterized by technological innovation, product differentiation, and the need for strong distribution networks to reach farmers across China.

Clientes Clave

  • Farmers in China
  • Agricultural distributors
  • Agricultural cooperatives
  • Large-scale agricultural operations
Confianza de la IA: 69% Actualizado: 17 mar 2026

Finanzas

Gráfico e información

Precio de la acción de Kiwa Bio-Tech Products Group Corporation (KWBT): Price data unavailable

Últimas noticias

No hay noticias recientes disponibles para KWBT.

Consenso de analistas

Calificación de Consenso

Recomendaciones agregadas de Compra/Mantener/Vender de Benzinga, Yahoo Finance y Finnhub para KWBT.

Objetivos de Precios

Análisis del precio objetivo de Wall Street para KWBT.

MoonshotScore

51/100

¿Qué significa esta puntuación?

El MoonshotScore califica el potencial de crecimiento de KWBT en una escala de 0 a 100 en múltiples factores, incluyendo innovación, disrupción del mercado, salud financiera e impulso.

Liderazgo: Ziqi Wang

CEO

Ziqi Wang serves as the CEO of Kiwa Bio-Tech Products Group Corporation. Information regarding Ziqi Wang's detailed career history, education, and previous roles is not available in the provided data. Further research would be needed to provide a comprehensive background.

Historial: Due to limited information, Ziqi Wang's key achievements, strategic decisions, and company milestones under their leadership cannot be accurately assessed. Additional data is required to evaluate their track record effectively.

Información del mercado OTC de KWBT

The OTC Other tier represents the lowest tier of the OTC market, indicating that Kiwa Bio-Tech Products Group Corporation may not meet the minimum financial standards or reporting requirements of higher tiers like OTCQX or OTCQB. Companies in this tier may have limited regulatory oversight and potentially higher risks compared to companies listed on major exchanges or higher OTC tiers. This tier often includes companies with distressed financials, early-stage ventures, or those that choose not to comply with stricter listing standards.

  • Nivel OTC: OTC Other
  • Estado de divulgación: Unknown
Liquidez: Trading volume for OTC Other stocks like KWBT is typically very low, resulting in wide bid-ask spreads. This can make it difficult to buy or sell shares without significantly impacting the price. Investors may experience challenges in executing large trades or exiting their positions quickly due to the limited liquidity.
Factores de riesgo OTC:
  • Limited financial disclosure
  • Low trading volume and liquidity
  • Potential for price manipulation
  • Higher risk of fraud or mismanagement
  • Lack of regulatory oversight
Lista de verificación de diligencia debida:
  • Verify the company's financial statements and SEC filings (if any).
  • Research the company's management team and their track record.
  • Assess the company's business model and competitive landscape.
  • Evaluate the company's legal and regulatory compliance.
  • Check for any red flags or warning signs.
  • Consult with a financial advisor.
  • Understand the risks associated with investing in OTC stocks.
Señales de legitimidad:
  • Strategic partnerships with reputable organizations
  • Positive media coverage or industry recognition
  • Experienced management team
  • Clear business plan and growth strategy
  • Audited financial statements (if available)

Preguntas Comunes Sobre KWBT

¿Cuáles son los factores clave para evaluar KWBT?

Kiwa Bio-Tech Products Group Corporation (KWBT) actualmente tiene una puntuación IA de 51/100, indicando puntuación moderada. Fortaleza clave: Proprietary bio-fertilizer technology. Riesgo principal a monitorear: Ongoing: Competition from larger agricultural companies with greater resources.. Esto no es asesoramiento financiero.

¿Qué es el MoonshotScore de KWBT?

KWBT actualmente puntúa 51/100 (Grado C) en el MoonshotScore, lo que sugiere calificación moderada. La puntuación evalúa el potencial de crecimiento, la salud financiera, el impulso del mercado y los factores de riesgo en 9 KPIs cuantitativos. Se recalcula diariamente con los últimos datos del mercado. Esta puntuación es solo informativa.

¿Con qué frecuencia se actualizan los datos de KWBT?

Los precios de KWBT se actualizan en tiempo real durante el horario del mercado estadounidense (9:30-16:00 ET, días laborables). Los fundamentales se actualizan después de los informes trimestrales o anuales. Las calificaciones de analistas y las perspectivas de IA se actualizan diariamente. Las noticias se agregan continuamente de fuentes financieras.

¿Qué dicen los analistas sobre KWBT?

La cobertura de analistas para KWBT incluye calificaciones de consenso (compra, mantener, venta), objetivos de precio a 12 meses y estimaciones de ganancias de las principales firmas de investigación. Consulte la sección de Consenso de Analistas en esta página.

¿Cuáles son los riesgos de invertir en KWBT?

Las categorías de riesgo para KWBT incluyen riesgo de mercado, riesgo específico de la empresa (gestión, competencia), riesgo financiero (deuda, consumo de efectivo) y riesgo macroeconómico (tasas, inflación). Un riesgo clave identificado: Ongoing: Competition from larger agricultural companies with greater resources.. Un beta superior a 1,0 indica mayor volatilidad que el S&P 500. Revise la sección de Factores de Riesgo en esta página. Todas las inversiones conllevan riesgo de pérdida.

¿Cuál es la relación P/E de KWBT?

La relación P/E para KWBT compara el precio actual de la acción con sus ganancias por acción. Un P/E más alto puede indicar expectativas de crecimiento, mientras que un P/E más bajo puede sugerir valor. Consulte la pestaña de Financieros para métricas actuales.

¿Está KWBT sobrevalorada o infravalorada?

Determinar si Kiwa Bio-Tech Products Group Corporation (KWBT) está sobrevalorada o infravalorada requiere examinar múltiples métricas. Compare los ratios de valoración (P/E, P/S, EV/EBITDA) con pares del sector. Esto no es asesoramiento financiero.

¿Cuál es el rendimiento por dividendo de KWBT?

Kiwa Bio-Tech Products Group Corporation (KWBT) actualmente no paga un dividendo regular, o los datos de rendimiento no están disponibles. Consulte la pestaña de Financieros para información actual.

Descargo de responsabilidad: Este contenido es solo para fines informativos y no constituye asesoramiento de inversión. Siempre haga su propia investigación y consulte a un asesor financiero.

Recursos Oficiales

Análisis actualizado el Puntuación de IA actualizada diariamente
Fuentes de Datos y Metodología
Datos de mercado proporcionados por Financial Modeling Prep y Yahoo Finance. Análisis de IA por algoritmos propietarios de Stock Expert AI. Indicadores técnicos mediante cálculos estándar de la industria. Última actualización: .

Datos proporcionados solo con fines informativos.

Notas de análisis
  • Limited information available on the company's financials and operations.
  • OTC market carries inherent risks due to lower regulation and liquidity.
Fuentes de datos

Popular Stocks